Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhejiang Jiuzhou Pharmaceutical Co., Ltd
  6. News
  7. Summary
    603456   CNE100001W36

ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD

(603456)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it expects to receive CNY 88 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd

02/09/2021 EDT

Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced a private placement of common shares for gross proceeds of CNY 88,000,000 on February 9, 2021. The transaction includes participation from existing investor Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456). Post the closing, the registered capital of the company will increase from CNY 100,000,000 to CNY 107,457,627.12. The transaction has been approved by the board of directors of the company at the 7th directorate and the 2nd meeting of the 4th supervisory board, and does not need the shareholders’ approval.


ę S&P Capital IQ 2021
All news about ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
08/11Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Hal..
CI
04/27Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Fir..
CI
03/04Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY ..
CI
03/04Ruibo Pharmaceutical Co., Ltd. announced that it has received CNY 280 million..
CI
02/09Ruibo Pharmaceutical Technology Co., Ltd. announced that it expects to receiv..
CI
02/09Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it expects t..
CI
02/09Ruibo Pharmaceutical Co., Ltd. announced that it expects to receive CNY 280 m..
CI
01/29Zhejiang Jiuzhou Pharmaceutical Co., Ltd announced that it has received CNY 9..
CI
01/21Zhejiang Jiuzhou Biomedical Co., Ltd. announced that it has received CNY 50 m..
CI
2020Zhejiang Jiuzhou Biomedical Co., Ltd. announced that it expects to receive CN..
CI
More news
Financials
Sales 2021 3 675 M 568 M 568 M
Net income 2021 613 M 94,9 M 94,9 M
Net Debt 2021 - - -
P/E ratio 2021 68,4x
Yield 2021 0,58%
Capitalization 41 777 M 6 461 M 6 462 M
Capi. / Sales 2021 11,4x
Capi. / Sales 2022 9,38x
Nbr of Employees 3 586
Free-Float 49,5%
Chart ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Duration : Period :
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 50,25 CNY
Average target price 61,78 CNY
Spread / Average Target 22,9%
EPS Revisions
Managers and Directors
Zhi Hong Chen General Manager & Director
Yu Jie Sha Chief Financial Officer
Li Rong Hua Chairman
Meng Sheng Sun Chairman-Supervisory Board
Yuan Qiang Li Director-Technology, Research & Development
Sector and Competitors